Fundamental Analysis
52 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -3.4% | +18.7% | 2 / 3 | +1.2% | +2.69 pp | -0.33 pp | +22.3% | 0.02 | 11.50 | 6.888 | +1,2% | 1.243 | −0,6% | 11.50 | 14.90 | −22,8% |
| Pts | 0 | 0 | 8 | 0 | 8 | 4 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 42.800 (close price on 2026-10-19)EPS (TTM): 3.723
Financial charts
1.Revenue & growth
VND bn6.888Q2/26
1.Revenue & growth
VND bn6.888Q2/26
2.Profit & growth
VND bn1.167Q2/26
3.Profit mix (Penman)
VND bn6.153Q2/26
4.Margins & cost structure
%37.8%Q2/26
5.Returns & cash cycle
% · days102%Q2/26
6.Earnings quality & cash
VND bn3.391Q2/26
7.Asset structure
VND bn31.722Q2/26
8.Funding & debt health
VND bn · times31.722Q2/26
9.Revenue backlog
VND bn77,0Q2/26
10.Valuation
times · %11,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %910Q2/26
Adjusted EPS growth, latest quarter
-3.4%
Average adjusted EPS growth, 3 quarters
18.7%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26